Assenagon Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,852
| Closed | -$127K | – | 1413 |
|
|
2024
Q1 | $127K | Hold |
23,852
| – | – | ﹤0.01% | 1306 |
|
|
2023
Q4 | $148K | Hold |
23,852
| – | – | ﹤0.01% | 1330 |
|
|
2023
Q3 | $180K | Sell |
23,852
-51,539
| -68% | -$389K | ﹤0.01% | 1300 |
|
|
2023
Q2 | $729K | Hold |
75,391
| – | – | ﹤0.01% | 1010 |
|
|
2023
Q1 | $285K | Hold |
75,391
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q4 | $489K | Sell |
75,391
-73,412
| -49% | -$476K | ﹤0.01% | 1126 |
|
|
2022
Q3 | $1.32M | Sell |
148,803
-107,006
| -42% | -$951K | 0.01% | 840 |
|
|
2022
Q2 | $2.55M | Sell |
255,809
-98,716
| -28% | -$984K | 0.01% | 719 |
|
|
2022
Q1 | $4.11M | Sell |
354,525
-100,465
| -22% | -$1.16M | 0.01% | 556 |
|
|
2021
Q4 | $5.05M | Buy |
454,990
+439,339
| +2,807% | +$4.88M | 0.01% | 482 |
|
|
2021
Q3 | $144K | Buy |
+15,651
| New | +$144K | ﹤0.01% | 1206 |
|